GLP-1 trends 2025: real-world data, patient outcomes & future therapies
Few areas of medicine have captured public interest over the past two years quite like...
Few areas of medicine have captured public interest over the past two years quite like...
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
(Part 1) When clients see real-world data (RWD) in HealthVerity Marketplace, it may appear...
Electronic Health Records (EHR): What they are and how to use them in real-world data Electronic...
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
In epidemiology, statistical power determines whether a study can accurately detect an effect of a given size with a specified probability, typically 80% or higher. When studies fall below that threshold, the consequences extend well beyond inconclus...